Erlotinib Hydrochloride API

Name	Erlotinib Hydrochloride
Chinese name	盐酸厄洛替尼
Cas Number	183319-69-9
Source	India/Europe
Qualifications	USDMF/-/-/-/-

Erlotinib hydrochloride is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor developed by Roche Pharmaceuticals Co., Ltd. It acts by blocking signal pathways and delaying tumor growth and spread. In November 2004, it was approved by the FDA for marketing. Erlotinib hydrochloride is the world's first small molecule inhibitor that acts on epidermal growth factor receptor tyrosine kinase, and it is also the first small molecule drug for targeted therapy of lung cancer. It can specifically target tumor cells and inhibit The formation and growth of tumors. Erlotinib is a representative drug of anti-tumor molecular targeted drugs, and it occupies an important position in the treatment of non-small cell lung cancer.

Hot Tags: erlotinib hydrochloride api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Teriflunomide API, Fondaparinux API, Salmeterol Xinafoate API, Lurasidone Hydrochloride API, Perindopril Tert butylamine Salt API, Canagliflozin API

• Previous: Tafluprost API
• Next: Tofacitib Citrate API